• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病住院患者的药物不良事件

Adverse drug events in hospitalized patients with chronic kidney disease.

作者信息

Hassan Y, Al-Ramahi R J, Aziz N A, Ghazali R

机构信息

School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.

出版信息

Int J Clin Pharmacol Ther. 2010 Sep;48(9):571-6. doi: 10.5414/cpp48571.

DOI:10.5414/cpp48571
PMID:20860910
Abstract

BACKGROUND AND OBJECTIVE

Adverse drug events (ADEs) are a common cause of hospitalization and in-hospital complications. The aim of this study was to determine the rates, types, severity and preventability of pre-admission and in-hospital ADEs in patients with chronic kidney disease (CKD).

METHODS

This study was conducted at the nephrology unit at Penang General Hospital. A random sample of 300 adult patients with CKD was included. Medical records and charts were reviewed by a clinical pharmacist every work day to find any evidence of errors or complications related to drug use. If a suspected ADE was found, further investigations were carried out to assess the causality, severity and preventability of the event.

RESULTS

A total of 159 ADEs were reported in 122 (40.7%) of the patients. We found 86 suspected pre-admission ADEs in 68 (22.7%) of the patients. These were either the cause of admission for some patients or discovered by the initial physical examination and laboratory investigations. During hospitalization, 64 (21.3%) patients had 73 suspected ADEs. Out of the total 159 suspected ADEs, it was highly probable that 31 events were due to medication, while 61 were of lower probability, and 67 were merely possible. A total of 48 (30.2%) events was considered preventable. 46 events (28.9%) were serious, 93 (58.5%) were less serious and 20 (12.6%) were insignificant. The medication classes most frequently involved in ADEs were diuretics, antibacterials, drugs used for diabetes mellitus, antithrombotic agents, mineral supplements and antihypertensive drugs.

CONCLUSION

ADEs are very common in hospitalized CKD patients, and some of these events are preventable. The service of a clinical pharmacist may help to reduce ADEs.

摘要

背景与目的

药物不良事件(ADEs)是住院及院内并发症的常见原因。本研究旨在确定慢性肾脏病(CKD)患者入院前及住院期间ADEs的发生率、类型、严重程度及可预防性。

方法

本研究在槟城总医院肾病科进行。纳入300例成年CKD患者的随机样本。临床药师每个工作日查阅病历和图表,以查找与药物使用相关的任何错误或并发症证据。若发现疑似ADEs,进一步调查以评估事件的因果关系、严重程度及可预防性。

结果

122例(40.7%)患者共报告159例ADEs。我们在68例(22.7%)患者中发现86例疑似入院前ADEs。这些对部分患者而言是入院原因,或通过初次体格检查及实验室检查发现。住院期间;64例(21.3%)患者发生73例疑似ADEs。在总共159例疑似ADEs中,31例事件很可能由用药引起,61例可能性较低,67例仅为可能。共48例(30.2%)事件被认为可预防。46例(28.9%)事件严重,93例(58.5%)不太严重,20例(12.6%)不严重。ADEs中最常涉及的药物类别为利尿剂、抗菌药物、糖尿病用药、抗血栓药物、矿物质补充剂及抗高血压药物。

结论

ADEs在住院CKD患者中非常常见,其中一些事件是可预防的。临床药师的服务可能有助于减少ADEs。

相似文献

1
Adverse drug events in hospitalized patients with chronic kidney disease.慢性肾脏病住院患者的药物不良事件
Int J Clin Pharmacol Ther. 2010 Sep;48(9):571-6. doi: 10.5414/cpp48571.
2
Risk factors for hospital admissions associated with adverse drug events.与药物不良事件相关的住院风险因素。
Pharmacotherapy. 2013 Aug;33(8):827-37. doi: 10.1002/phar.1287. Epub 2013 May 17.
3
Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan.抗生素致住院患者不良药物反应和不良药物事件的因果关系和可预防评估:巴基斯坦拉合尔的一项多中心、横断面研究。
PLoS One. 2018 Jun 27;13(6):e0199456. doi: 10.1371/journal.pone.0199456. eCollection 2018.
4
Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study.描述和预防药物不良事件导致急诊就诊的情况:一项前瞻性的 1 年观察性研究。
BMC Pharmacol Toxicol. 2019 Apr 27;20(1):21. doi: 10.1186/s40360-019-0297-7.
5
Incidence of adverse drug events in an academic hospital: a prospective cohort study.学术医院中药物不良事件的发生率:一项前瞻性队列研究。
Int J Qual Health Care. 2013 Dec;25(6):648-55. doi: 10.1093/intqhc/mzt075. Epub 2013 Oct 17.
6
Hospital admissions to geriatric ward related to adverse drug events: a cross-sectional study from the Czech Republic.老年病房与药物不良事件相关的住院情况:来自捷克共和国的一项横断面研究。
Int J Clin Pharm. 2021 Oct;43(5):1218-1226. doi: 10.1007/s11096-021-01237-y. Epub 2021 Mar 24.
7
Hospital admissions caused by adverse drug events: an Australian prospective study.药物不良事件导致的住院情况:一项澳大利亚前瞻性研究。
Aust Health Rev. 2014 Feb;38(1):51-7. doi: 10.1071/AH12027.
8
Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission.入院时预期寿命有限的晚期慢性病患者的药物不良事件。
Eur J Clin Pharmacol. 2017 Jan;73(1):79-89. doi: 10.1007/s00228-016-2136-8. Epub 2016 Oct 4.
9
[Prevalence and factors associated with preventable adverse drug events leading to hospital admission].[导致住院的可预防药物不良事件的患病率及相关因素]
Farm Hosp. 2006 May-Jun;30(3):161-70. doi: 10.1016/s1130-6343(06)73967-8.
10
The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: the JADE study.日本精神科住院患者药物不良事件和用药错误的流行病学:JADE研究
BMC Psychiatry. 2016 Aug 30;16(1):303. doi: 10.1186/s12888-016-1009-0.

引用本文的文献

1
Adverse events with co-prescription of angiotensin receptor blockers and clarithromycin compared to azithromycin: A population-based retrospective cohort study.与阿奇霉素相比,血管紧张素受体阻滞剂与克拉霉素联合处方的不良事件:一项基于人群的回顾性队列研究。
Pharmacotherapy. 2025 Jul;45(7):414-425. doi: 10.1002/phar.70032. Epub 2025 Jul 17.
2
Drug stewardship in chronic kidney disease to achieve effective and safe medication use.慢性病肾脏病中的药物管理以实现有效的、安全的药物使用。
Nat Rev Nephrol. 2024 Jun;20(6):386-401. doi: 10.1038/s41581-024-00823-3. Epub 2024 Mar 15.
3
GFR estimation is complicated by a high incidence of non-steady-state serum creatinine concentrations at the emergency department.
在急诊科,血清肌酐浓度经常处于非稳态,这使得肾小球滤过率(GFR)的估算变得复杂。
PLoS One. 2021 Dec 29;16(12):e0261977. doi: 10.1371/journal.pone.0261977. eCollection 2021.
4
Design, development, and deployment of an indication- and kidney function-based decision support tool to optimize treatment and reduce medication dosing errors.设计、开发并部署一种基于适应症和肾功能的决策支持工具,以优化治疗并减少用药剂量错误。
JAMIA Open. 2021 Jun 30;4(2):ooab039. doi: 10.1093/jamiaopen/ooab039. eCollection 2021 Apr.
5
Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases.药物相互作用作为肾病患者药物不良反应原因的可能性。
J Res Pharm Pract. 2020 Jun 26;9(2):121-124. doi: 10.4103/jrpp.JRPP_20_38. eCollection 2020 Apr-Jun.
6
Medication use, renin-angiotensin system inhibitors, and acute care utilization after hospitalization in patients with chronic kidney disease.慢性肾脏病患者住院后药物使用、肾素-血管紧张素系统抑制剂和急性护理利用。
J Renin Angiotensin Aldosterone Syst. 2020 Jul-Sep;21(3):1470320320945137. doi: 10.1177/1470320320945137.
7
Quality assessment and cost saving of renal dosing recommendation by clinical pharmacists at medical wards in Thailand.泰国医疗病房临床药师的肾脏剂量建议的质量评估和成本节约。
Int J Clin Pharm. 2020 Apr;42(2):610-616. doi: 10.1007/s11096-020-01016-1. Epub 2020 Mar 27.
8
Agreement between renal prescribing references and determination of prescribing appropriateness in hospitalized patients with chronic kidney disease.慢性肾脏病住院患者肾科用药医嘱与用药适宜性判断标准的符合程度。
QJM. 2017 Oct 1;110(10):623-628. doi: 10.1093/qjmed/hcx086.
9
Primary and tertiary health professionals' views on the health-care of patients with co-morbid diabetes and chronic kidney disease - a qualitative study.初级和三级医疗保健专业人员对合并糖尿病和慢性肾脏病患者的医疗保健看法——一项定性研究
BMC Nephrol. 2016 May 18;17(1):50. doi: 10.1186/s12882-016-0262-2.
10
Evaluation of potential drug- herb interactions among a group of Palestinian patients with chronic diseases.一组患有慢性病的巴勒斯坦患者中潜在药物与草药相互作用的评估。
BMC Complement Altern Med. 2015 Jul 11;15:221. doi: 10.1186/s12906-015-0764-7.